Home > Healthcare > Biotechnology > Biotechnology R&D > Human Microbiome Market

Human Microbiome Market Size

Report ID: GMI6538
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Human Microbiome Market Size

Human Microbiome Market size was valued at USD 824.4 million in 2023 and is expected to reach USD 6.47 billion by 2032, registering a CAGR of 25.7% till 2032. The growing prevalence of lifestyle-related diseases and the rising geriatric population has propelled the demand for innovative healthcare solutions.

To get key market trends

Download Free Sample

As these factors contribute to an upsurge in chronic conditions, the significance of harnessing the potential of the human microbiome in disease management becomes increasingly apparent. Additionally, the growing demand for precision medicine, tailored to individual patient needs, has spotlighted the microbiome's pivotal role in personalizing treatment strategies.

Human Microbiome Market Report Attributes
Report Attribute	Details
Base Year:	2023
Human Microbiome Market Size in 2023:	USD 842.4 Million
Forecast Period:	2024 to 2032
Forecast Period 2024 to 2032 CAGR:	25.7%
2032 Value Projection:	USD 6.47 Billion
Historical Data for:	2018 to 2023
No. of Pages:	180
Tables, Charts & Figures:	269
Segments covered:	Site, Application, Disease, Product, and Region
Growth Drivers:	Increasing burden of lifestyle-related diseases and the growing geriatric population Increasing funding initiatives and government program Increasing demand precision medicine Long regulatory pathways and high development costs
Pitfalls & Challenges:	Ethical and safety concern

Learn more about the key segments shaping this market

Download Free Sample

The human microbiome refers to the collection of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit various parts of the human body. These microorganisms live in and on the human body, forming complex ecosystems that play a crucial role in maintaining health and contributing to various physiological processes. Human microbiome industry is a rapidly growing field within the biotechnology and healthcare industries that focuses on understanding and harnessing the potential of the human microbiome.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The Global market value for human microbiome was USD 824.4 million in 2023 and is expected to reach USD 6.47 billion by 2032, backed by the growing prevalence of lifestyle-related diseases.

The digestive tract segment held largest market share of 31.9% in 2022 and will continue growing by 2032 due to the increasing awareness of the pivotal role that the gut microbiome plays in overall health.

North America market revenue was USD 261.2 million in 2022 and is anticipated to record around 24.9% CAGR between 2023-2032 attributed to the advancements in microbiome research and growing emphasis on personalized medicine in the region.

Seres Therapeutics, Enterome, Second Genome Inc., DuPont, Synthetic Biologics, Inc., Synlogic, Vedanta Biosciences, Inc., Metabiomics Corporation, Microbiome Therapeutics LLC, and 4D pharma plc. among others.